The other group at the highest risk when it comes to RSV is children under age five, and specifically infants—especially ...

[8] Respiratory syncytial virus (RSV) is a highly contagious and potentially serious ... GSK prioritises innovation in vaccines and specialty medicines, maximising the increasing opportunities to ...

Saskatchewan is expecting a new shipment of updated COVID-19 vaccines next week, after a supply hiccup meant some couldn’t ...

On Thursday, Moderna Inc. (NASDAQ:MRNA) reported third-quarter revenue of $1.83 billion, beating the consensus of $1.25 ...

US mRNA specialist Moderna today announced Health Canada has approved mRESVIA (respiratory syncytial virus mRNA vaccine) for active immunization for the prevention of lower respiratory tract disease ...

Bank of America Securities analyst Alec Stranahan reiterated a Hold rating on Moderna (MRNA – Research Report) today and set a price ...

Moderna said on Friday Canada's health regulator has approved its vaccine for respiratory syncytial virus in adults 60 years ...

Recruitment is underway for a clinical trial testing a vaccine candidate produced with The University of Queensland's molecular clamp technology against life-threatening respiratory viruses.

Moderna ( (MRNA) ) has released its Q3 earnings. Here is a breakdown of the information Moderna presented to its investors. Moderna, Inc. is a ...

Georgia’s father, a commercial pilot, is exposed to “thousands of people ... Nor is she allowed to buy the vaccine in B.C.

Good day, ladies and gentlemen, and welcome to the Dynavax Technologies' Third Quarter 2024 Financial Results Conference Call. As a reminder, this call is being recorded. At the end of the company's ...

The Cambridge-based company’s latest COVID shot was approved three weeks earlier than last year, according to a statement ...